November 5
• support ophthalmology pipeline • expert QP2 representative • develop model-based strategies for quantitative analyses • collaborate on study design and protocol development • maintain understanding of global regulatory expectations • mentor or supervise early career scientists
• a Ph.D. or equivalent degree with at least seven years of experience OR (a PharmD or equivalent degree with at least nine years of experience) OR (an MS or equivalent degree with at least 11 years of experience) • educational background in biopharmaceutics, pharmaceutical sciences, pharmacometrics, chemical/biomedical engineering, or a related field • exemplary record of increasing responsibility, independence, and demonstrated impact in driving drug development decisions through application of model-based approaches in the pharmaceutical industry • direct experience in regulatory interactions • proficiency in written and verbal communication, interdisciplinary collaboration, and problem scoping and planning • demonstrated ability to participate in and to lead an interdisciplinary team, and to oversee the work of other scientists • knowledge in modeling of complex therapeutics • flexibility to react rapidly to changing situations/environment • knowledge in ophthalmology and/or cardiometabolic clinical drug development programs • knowledge in modeling of complex ophthalmology therapeutics
• bonus eligibility • long term incentive if applicable • health care and other insurance benefits (for employee and family) • retirement benefits • paid holidays • vacation • sick days
Apply NowNovember 5
51 - 200
Director of Proposal Management at Stratacomm focusing on new business growth.
November 5
201 - 500
Director at Aduro Advisors managing client service in fund administration.
November 5
51 - 200
Lead CT Pastors editorial efforts, equipping church leaders with resources.
November 4
51 - 200
Oversee mortgage branch support and training for Texana Bank's retail branches.
November 4
201 - 500
Drive profitable growth for O’Neill Vintners via National Accounts management.